View in EDS PDF Full Text

Value and Risk of Class I and III Antiarrhythmic Drugs.

Saved in:
Bibliographic Details
Title: Value and Risk of Class I and III Antiarrhythmic Drugs.
Authors: Burkart, Felix1
Source: Pacing & Clinical Electrophysiology. Mar1994, Vol. 17 Issue 3, p467-472. 6p.
Subjects: Myocardial depressants, Arrhythmia treatment, Phenytoin, Mexiletine, Quinidine, Amiodarone, Cardiovascular agents
Abstract: Discusses the value and risk of class one and three antiarrhythmic drugs. Phenytoin; Mexiletine; Aprindine; Encainide; Quinidine; Amiodarone; Prospective randomized clinical trial in patients at risk after myocardial infarction where physicians to avoid the pitfalls of previous antiarrhythmic trials.
Database: Engineering Source
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 17471774
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Value and Risk of Class I and III Antiarrhythmic Drugs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Burkart%2C+Felix%22">Burkart, Felix</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pacing+%26+Clinical+Electrophysiology%22">Pacing & Clinical Electrophysiology</searchLink>. Mar1994, Vol. 17 Issue 3, p467-472. 6p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Myocardial+depressants%22">Myocardial depressants</searchLink><br /><searchLink fieldCode="DE" term="%22Arrhythmia+treatment%22">Arrhythmia treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Phenytoin%22">Phenytoin</searchLink><br /><searchLink fieldCode="DE" term="%22Mexiletine%22">Mexiletine</searchLink><br /><searchLink fieldCode="DE" term="%22Quinidine%22">Quinidine</searchLink><br /><searchLink fieldCode="DE" term="%22Amiodarone%22">Amiodarone</searchLink><br /><searchLink fieldCode="DE" term="%22Cardiovascular+agents%22">Cardiovascular agents</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Discusses the value and risk of class one and three antiarrhythmic drugs. Phenytoin; Mexiletine; Aprindine; Encainide; Quinidine; Amiodarone; Prospective randomized clinical trial in patients at risk after myocardial infarction where physicians to avoid the pitfalls of previous antiarrhythmic trials.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=17471774
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/j.1540-8159.1994.tb01414.x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 467
    Subjects:
      – SubjectFull: Myocardial depressants
        Type: general
      – SubjectFull: Arrhythmia treatment
        Type: general
      – SubjectFull: Phenytoin
        Type: general
      – SubjectFull: Mexiletine
        Type: general
      – SubjectFull: Quinidine
        Type: general
      – SubjectFull: Amiodarone
        Type: general
      – SubjectFull: Cardiovascular agents
        Type: general
    Titles:
      – TitleFull: Value and Risk of Class I and III Antiarrhythmic Drugs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burkart, Felix
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 03
              Text: Mar1994
              Type: published
              Y: 1994
          Identifiers:
            – Type: issn-print
              Value: 01478389
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pacing & Clinical Electrophysiology
              Type: main
ResultId 1